Income statement
USD
Annual
| Metric | 2023 | 2022 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 864K | 5M | 14M |
| Gross Profit | 0 | -5 | -57K | 2M | 5M |
| Operating Income | -11 | -24 | -274K | 940K | 4M |
| EBITDA | 0 | 0 | 431K | 2M | 4M |
| Net Income | -11 | -24 | -316K | -62K | 1M |
| EPS (Diluted) | — | — | — | — | — |
Industrials
Live Price
Offline$0.0003
+0.00% today
1Y Change
-50.00%
Window
Jun 23, 2025 → Jun 5, 2026
Coverage: 244 bars · Jun 23, 2025 → Jun 5, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sino Bioenergy Corp. (SFBE) is a Industrials stock with listed on OTC. The stock last traded around $0.00 and down 50.0% across the available one-year price window (Jun 23, 2025 → Jun 5, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow +74.5% with operating margin 0.0% and ROIC 228.3%. Stock Foundry combines SFBE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SFBE
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SFBE Max Drawdown
-66.67%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SFBE and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$13.9M
+160.3% YoY
FY Net Income
$1.4M
+2372.7% YoY
Free Cash Flow
$2.3M
+234.6% YoY
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2023 | 2022 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 864K | 5M | 14M |
| Gross Profit | 0 | -5 | -57K | 2M | 5M |
| Operating Income | -11 | -24 | -274K | 940K | 4M |
| EBITDA | 0 | 0 | 431K | 2M | 4M |
| Net Income | -11 | -24 | -316K | -62K | 1M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Cash & Equivalents | 0 | 0 | 50K | 77K | 282K |
| Total Assets | 0 | 0 | 116M | 117M | 115M |
| Total Liabilities | 36 | 26 | 24M | 24M | 23M |
| Shareholder Equity | -35 | -24 | 82M | 82M | 82M |
| Total Debt | 32 | 26 | 4M | 4M | 3M |
| Net Debt | 30 | 24 | 4M | 4M | 3M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
3M
+289.6% YoY
Capital Expenditures
934K
-46687800.0% YoY
Free Cash Flow
2M
+234.6% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
37.0%
Debt / Equity
-0.90x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.